 ÏÊ»¨( 219)  ¼¦µ°( 0)
|
* q1 Y% K9 z" A, c. N9 P$ P& u! ^' i" W5 b
3 h8 p; E. V+ G+ E
´ó¼ÒºÃ£¬
( ~$ ?" ^& u8 d b% R" n
& L0 T2 l' U ?! V»¶Ó¹âÁÙ½¡¿µÓªÑøÕ¾É̳ǡ£ÎÒÊǽ¡¿µÓªÑøÕ¾µÄ°æÖ÷¡£ÎÒ±ÏÒµÓÚU Of A ÓªÑøÏµ¡£Ä¿Ç°¾ÓªÓªÑø²úÆ·¡£ÎÒËù¾ÓªµÄÓªÑø²úÆ·±£Öʱ£Á¿¡£¶øÇÒÔÚͬÑùµÄÆ·ÅÆÀÎÒ±£Ö¤¼ÛÇ®×îµÍ¡£ ¿µ¼ÓÃÀ²úÆ·ÊÇÎÒĿǰ¾ÓªµÄÖ÷Òª²úÆ·Ö®Ò»¡£ÎªÁËÄúµÄ·½±ã£¬ËùÓвúÆ·µÄÏêϸÇé¿öºÍ¼ÛÇ®¿ÉÒÔµã»÷ÕâÀïÕÒµ½
" [0 J9 [4 t+ t2 g3 o1 y/ A[url]http://www.edmontonchina.ca/forumdisplay.php?fid=912 k: f5 l! w9 s
3 P5 l1 w' e4 ]; P: X9 \- F# q# \ J¶©¹º×Éѯ£º£¨780£©669-6586²úÆ·  780-249-1365$ F: j* i$ B* Q s0 b: ^4 ?
Email£º c.health@hotmail.com
8 e E9 o- Y4 {' `
; h& ~ z ?$ F3 W9 m9 A4 s¿µ¼ÓÃÀ²úÆ·¼ò½é£º
1 D6 N# E$ ^0 _# A' z- f
" R5 }" G$ W. Y( w- ^' Z I3 }8 S¼ÓÃÀ¿ÆÑÐÖÆÒ©ÓÐÏÞ¹«Ë¾Î»ì¶×ÔÈ»×ÊÔ´·á¸»µÄ¼ÓÄô󰲴óÂÔÊ¡£¬Ç±ÐÄÑÐÖÆÌìȻҩÁƽ¡¿µ®bÆ·¡£ÎÒÃǵÄ×î´óÐÄÔ¸Êǽ«ÓÅÖÊÌìȻֲÎï»òº£ÑóÉúÎᆱ»ª£¬½áºÏ×ÔÈ»Éú»îµÄ½¡¿µÀíÄîÍÆ½é¸øËùÓмÒÍ¥£¬ ÁîÄãºÍ¼ÒÈËÊܵ½´¿×ÔÈ»µÄ±£»¤£¬×à³öÇáËɽ¡¿µÔÏÀÖ¡£
$ v2 x N& w/ M
1 ?# n7 G. |1 z& X¼ÓÃÀ¿ÆÑÐÖÆÒ©ÊǼÓÄôó±¾ÍÁ¾ß¹æÄ£ºÍʵÁ¦µÄÖÆÒ©¹«Ë¾¡£ÎÒÃǵÄÖ÷ÒªÒµÎñ°üÀ¨ÓÅÖʱ£½¡Æ·µÄÉú®b¡¢ÁãÊÛ¡¢Åú·¢£¬¸ü ‘´Óʸ߼¶±£½¡Æ·Éú®bµÄ³§¼ÒºÍ¸öÈËÌṩ¿É¿¿ÖÜÈ«µÄ¼Ó¹¤·þÎñ (OEM)¡£×Ô³ÉÁ¢ÒÁʼ£¬¼ÓÃÀ¿ÆÑÐ ²»¶ÏͶ·Å´óÁ¿×ÊÔ´Ñо¿ÌìÈ»½¡¿µÆ·¡£Ê®¶àÄêǰÒѳɹ¦½«ÌìÈ»º£±ªÓÍ¡¢ÉÈýÎÄÓãÓÍÔÓÍת»¯Îª¶àÖÖ±£½¡¹¦Ð§£¬ÈÝÒ×ÎüÊյĽ¡¿µ®bÆ·¡£ÆäUNCLE BILL Æ·ÅÆµÄÌìÈ»º£±ªÓÍ£¬ÉÓãÓÍ£¬ÂÑÁ×Ö¬µÈÌìÈ»®bÆ·Ê®¶àÄêÀ´Ò»Ö±±¸ÊÜÏû·ÑÕßÐÅÀµ£¬ÊÇ´ó¼Ò×ÔÓúÍÀ¡ÔùÇ×ÓѵÄÊ×Ñ¡ºÍÖ¸¶¨®bÆ·¡£
/ H' Z' j1 o- k; y4 J
1 L4 G9 R7 R4 [. e: _, H2 V3 A, |¶þÊ®ÔØ ¾Óª£¬ ¶þÊ®ÔØ³ÏÐÅ£¬ Ò»Èç¼ÈÍù. ¸ß¿Æ¼¼Í¶ÈëºÍ³¤¾QͶ×ʳɾÍÁ˼ÓÃÀ¿ÆÑÐÖÆÒ© ÔÚ½¡¿µ®bÆ·Òµ½çµÄÇ̳þµØÎ»£¬ÊµÁ¦²»ÈÝÖÃÒÉ¡£Ê±ÖÁ½ñÈÕ, ¼ÓÃÀ¿ÆÑÐÒÑ·¢Õ¹ ‘Ò»¼äÓÐʵÁ¦ºÍ¹æÄ£µÄÖÆÒ©¹«Ë¾¡£¼ÓÃÀµÄ¼¼ÊõÍÅÒ²ÈÕÒæ×³´ó£¬³ýÍøÂÞ±¾µØÒ½Ò©Ïµ¾«Ó¢Í⣬¸üÖØ½ðͶ×ÊÉ豸¾«Á¼µÄÒ©Æ·¼ìÑéʵÑéÊÒ£¬ ¶ÔÿÅú®bÆ·½øÐÐ Standard Operation Procedure (SOP)¼ì²â£¬½¨Á¢ÖÊÁ¿×·×Ù»ØÊÕϵͳ£¬ ¾ø¶Ô·ûºÏ¼ÓÄôóÎÀÉú²¿Ò©Îï¼à¹ÜÒªÇó, Æ·ÖÊ ‘Òµ½çÖ®¹Ú¡£ " T) |% ]" y' G P, E8 r/ U& I2 s$ D% G
}* p3 U: c- }, t4 W/ l
¼ÓÃÀ¿ÆÑÐÖÆÒ©´´Á¢ºÇ»¤ÉíÐĵġ°¿µ¼ÓÃÀ¡±£¬¡°±êÊ塱һϵÁб£½¡¾«Æ·£¬ ÁÆÐ§ÏÔÖø£¬ÉîÊÜÓüÒÐÅÀµ¡£¼ÓÃÀ¿ÆÑÐÊôÏÂËùÓЮbÆ·¾ùÒÑÉ걨¼ÓÄôóÎÀÉú²¿£¬ÊÇ×îÖµµÃÐÅÀµµÄÌìÈ»±£½¡Æ·Éú®b³§¼Ò¡¢ÖøÃû½¡¿µ®bÆ·¶À¼Ò´úÀíºÍÅú·¢ÉÌ¡£
- ^3 u! `+ F# b) z
: l: j' n5 C5 m¼ÓÃÀ¿ÆÑÐÉèÓжàÌõÏȽøµÄÉú®bÏߣ¬´ÓÖÆÔìµ½°ü×°¸÷ÖÖÉú®b³ÌÐò£¬¾ùÓɵçÄÔ¿ØÖÆ£¬²¢ÓµÓÐÉ豸ÍêÉÆµÄʵÑéÊÒ£¬¶ÔËùÓвÄÖʼ°ÖÆ³ÉÆ·½øÐÐÑϸñ²âÊÔ£¬·¢»Ó¿ÆÑ§¹ÜÀíµÄ³¬×¿Ð§ÄÜ¡£¼ÓÃÀµÄרҵÍŶӼá³ÖÒÔÆ·ÖÊΪ±¾£¬Á¦ÕéÍêÃÀ£¬²»¶ÏÇó½øºÍ´´Ð¡£
7 N) g, _# X8 X1 I$ {" R' ]( p7 f' i
3 `0 {7 ~; X" }* T) y7 O¼ÓÃÀ¿ÆÑÐÓµÓÐÉ豸ÍêÉÆµÄʵÑéÊÒ£¬ ÎÒÃǵÄרҵ¼¼ÊõÔ±¶Ô¸÷ÖÖÔÁϺÍÖÆ³ÉÆ·½øÐзÖÎö£¬ È·±£ÔÁϸßЧÐÔ£¬²¢Ñϸñ²âÊÔÿÅú²úÆ·µÄÖÊÁ¿ºÍ°²È«ÐÔ¡£¼ÓÃÀ¿ÆÑÐÖÆÒ©Ëù²ÉÓÃÔ²ÄÁÏ£¬ ÖÆÔì¹ý³ÌºÍ³ÉÖÊÁ¿¾ù·ûºÏ«ÃÀ¹úÒ©µä» * (US Pharmacopoeia (USP))±ê×¼£¬²¿·ÖÔÁϺͮbÆ·ÉõÖÁ³¬¹ý´Ë±ê×¼¡£
) d: Z, u. Y5 W6 |, o6 f1 W- p, Z) E% ?, O# }" o8 [
¼ÓÃÀ¿ÆÑÐÖÆÒ©µÄרҵ¾«Ó¢ÓÐÀ´×Ô±±ÃÀÖøÃû´óѧҽҩϵµÄ˶ʿºÍ ²©Ê¿£¬ ¼ÈÓÐÀ´×ÔÖйúÌìȻҩÎïÓë·ÂÉúÒ©Îï¹ú¼ÒÖØµãʵÑéÊÒ£¬»¹Óб±ÃÀÖÆÒ©ÐÐÒµ¾Ñé·á¸»µÄ¼¼Ê¦¡£ËûÃǶÔÌìÈ»®bÆ·µÄ¹¦Ð§ºÍÒ©ÀíÌØÐÔÓÐÉîÇÐÁ˽⡣¼ÓÃÀ¿ÆÑÐÖÆÒ©ÒѲ¼À³¿Ë´óѧ£¬ POLECNECTARÂ̷佺¹«Ë¾µÈ½øÐпÆÑкÏ×÷£¬²»¶Ï¸ÄÁ¼Ñз¢²úÆ·£¬ÎñÇó¸øÓè¹Ë¿Í×î¼ÑÆ·ÖÊ¡£# E4 H4 N. w( S, J" P5 m9 }
2 P1 w) d# L4 R" D6 W8 j7 }* \[ ±¾Ìû×îºóÓÉ ½¡¿µÓªÑøÕ¾ ÓÚ 2008-11-17 12:54 ±à¼ ]& a8 f, G+ X4 o" J2 U
gmp.gif (9.82 KB, ÏÂÔØ´ÎÊý: 36)6 T9 }5 `+ j2 F& G
GMO Approval% R2 w: M+ m4 G- `$ @
4 h+ N% K: l" o7 |! {5 a/ r* A
site_lis.gif (14.48 KB, ÏÂÔØ´ÎÊý: 16)) D" Z7 O& u% n4 F9 {
Canadian Licence6 {+ O, N6 i, ]: b. A
( \! I4 Z0 \/ L1 j
|
|